Pharmagest Interactive : 2016 HY RESULTS

Villers-lès-Nancy, France, 12 September 2016 - 07:00 (CET)

PRESS RELEASE Net profit up 12.5% in first-half 2016

€ millions	H1 2016	H1 2015	Change
Turnover (1 January to 30 June)	63.53	56.19	13.1%
Operating income	15.61	14.04	11.2%
Net income	10.45	9.29	12.5%
Net income - Group share	10.01	9.26	8%
Basic earnings per share (in €)	0.67	0.62	8%

The Board of Directors of PHARMAGEST INTERACTIVE reviewed and approved the accounts for H1 2016 during its meeting on 9 September 2016, chaired by Thierry CHAPUSOT. The statutory auditors performed an interim review of the half-year consolidated financial statements.

• Earnings rose to 30 June 2016

  The PHARMAGEST Group turnover rose 13.1% compared with the same period in 2015. Each of the four Divisions in the Group reported a solid level of growth. The contribution of growth drivers to total turnover increased, confirming the suitability of the Group's investments during the first half of 2016.

  Operating profit rose 11.2% to €15.61 million.

  Net profit came in at €10.45 million (12.5% growth) and net profit attributable to equity holders of the parent climbed 8% year-on-year.

  As at 30 June 2016, basic earnings per share were €0.67 (up from €0.62 at 30 June 2015 - proforma, following the stock split on 5 August 2015).

• Consolidated balance sheet - key data

  The PHARMAGEST Group's cash position improved with available liquidity of €61.71 million at 30 June 2016, versus €52.35 million at the end of first-half 2015.

  Equity capital was €91 million at 30 June 2016.

• Selected financial information for first-half 2016

  • February 2016: Groupe DOmedic Inc. a PHARMAGEST INTERACTIVE subsidiary, signed a strategic partnership agreement with TELUS Health, the Canadian leader in digital health solutions. Thanks to this technology alliance, companies offer an integrated treatment compliance solution for pharmacists and care homes in Canada;

  • March 2016: MALTA INFORMATIQUE announced the acquisition of DICSIT INFORMATIQUE, the specialist in information systems for HADs (Hospitals at

Home), SSIADs (Home-based nursing services) and CLIC networks (Local Information and Coordination Centres for older people). The acquisition adds to MALTA INFORMATIQUE's offering with valuable new expertise in the promising hospital at home and home care market;

• April 2016: following the "36 more months at home" pilot, the project has progressed to the operational phase with the support of the North-East Caisse d'Assurance Retraite et de la SAnté au Travail (CARSAT Nord-Est). The project continues to develop innovative solutions to preserve autonomy and maintain the elderly at home;

• June 2016: the Group PHARMAGEST made a further investment in the innovative home care sector with the acquisition of a majority stake in NOVIATEK, a start-up that focuses on smart home projects.

• Outlook for the second half of 2016

  The PHARMAGEST Group confirms the strong momentum in its growth drivers and remains confident that growth in the second half of 2016 will be in line with the first half:

  • The PHARMAGEST Group is continuing its strategy of innovation in the Solutions for Pharmacy Division - Europe and offers three new ranges with the potential for significant recurring business;

  • The Solutions for sanitary and medico-social establishments Division will step up efforts to achieve industrial and operating synergies between its subsidiaries, MALTA and DICSIT;

  • The PHARMAGEST Group will continue to accelerate in the Solutions for e-Health Division its drive to install innovative solutions in patients' homes;

  • The Fintech Division aims to steadily expand the scope of its platform's users.

The Group is maintaining its policy of developing solutions in health IT, computerised systems and home care technologies to meet the needs of healthcare professionals and patients and to enhance coordination between providers.

Financial calendar:

• Midcap Event on 5 and 6 October 2016, Paris

• Publication of Q3 turnover on 16 November 2016

About the PHARMAGEST Group:

The PHARMAGEST Group is the French leader in pharmacy information technology, with a 43.5% share of the market and over 800 employees. The strategy of the PHARMAGEST Group is based on a core business - innovating in information technology to improve healthcare - and on the development of two priority focuses: services and technologies for healthcare professionals, notably support for pharmacists in monitoring patient compliance; and technology for improving the efficacy of healthcare systems.

To roll out that strategy, the PHARMAGEST Group has developed specialised businesses, including pharmacy IT, e-Health solutions, solutions for healthcare professionals, solutions for laboratories, connected health devices and apps, and a sales financing marketplace.

These businesses are divided into 4 Divisions: the Solutions for Pharmacy Division - Europe, the Solutions for Sanitary and Medico-Social Establishments Division, the Solutions for e-Health Division, and the FinTech Division.

Listed on Euronext Paris™ - Compartment B

Indices: ENTERNEXT TECH 40, CAC ® SMALL and CAC ® All-Tradable by inclusion Eligible for the Long-Only Deferred Settlement Service (SRD)

ISIN: FR0012882389 - Reuters: PHA.PA - Bloomberg: PMGI FP

PHARMAGEST shares are eligible for France's Equity Savings Plan intended to finance SMEs (PEA-PME)

For all the latest news, go to www.pharmagest.com

CONTACTS

Chairman of the Board of Directors

Thierry CHAPUSOT

Managing Director:

Dominique PAUTRAT

Tel. [phone] - [e-mail]

Analyst and Investor Relations:

Chief Financial Officer: Jean-Yves SAMSON

Tel. [phone] - [e-mail]

Press Relations:

FIN'EXTENSO - Isabelle APRILE

Tel. [phone] - [e-mail]